doi: 10.1016/j.jaci.2011.01.063 71
A new randomized controlled trial suggests it might, especially when modified with medium-chain triglycerides (MCTs)
It improves the communications of neurons with the body's nervous system and participates in the action of serotonin, a neurotransmitter that plays a role in appetite and mood
Provider selection of a GLP-1 medication should balance efficacy data, your metabolic profile, genetic predispositions, affordability, and injection/oral preference
Tirzepatide is a first-in-class dual incretin receptor agonist a single molecule that activates both the GIP (glucose-dependent insulinotropic polypeptide) and the GLP-1 (glucagon-like peptide-1) receptors, which is why it is often nicknamed a twincretin. [7] By engaging two incretin pathways it enhances glucose-dependent insulin secretion, promotes satiety, and delays gastric emptying, producing large effects on both glycemic control and bodyweight
